Take a look out our infographic on the landscape of cell therapy regulation. Do you agree with our poll results? Let us know!
As part of the spotlight, we conducted weekly polls asking you, our expert RegMedNet members, what your opinions were on some key questions in cell therapy regulation. However, public, industry and academic perceptions of cell therapy regulation vary from country to country, so to show the full story, we’ve drawn from existing data sources. These include the FDA, ClinicalTrials.gov and the final report on the REMEDiE Project: Regenerative Medicine in Europe, based at the University of York in the UK.
Register now for an expert analysis of the cell therapy regulation landscape, featuring James L. Sherley (Director, Assymetrex, LLC, Mark W. Sawicki (Chief Commercial Officer, Cryoport), Jacqueline Barry (Chief Clinical Officer, Cell and Gene Therapy Catapult) and Patrick Bedford (Manager, Clinical Translation & Regulatory Affairs, CCRM). Join us for this free event and what is sure to be an insightful discussion!
Surprised by the results of the survey? Have comments you’d like to add? Please share your
thoughts in the comments section below – we’d love to know what you think.